- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bayer AG NA (BAYGn)
The Bayer share price today is 56.57, view ETR BAYGn stock exchange data. Track the latest Bayer share price with real-time updates on BAYGn stock performance including market cap, day range, 52-week range and dividend yield. Access BAYGn charts, earnings dates and analyst estimates to support your investment decisions.
Real-time derived
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| BAYGn | · | Derived | · | EUR | |
| 0P6S | · | London | · | EUR | |
| BAYGn | · | Xetra | · | EUR | |
| BAYGn | · | Switzerland | · | CHF | |
| BAYG | · | Milan | · | EUR | |
| BAYGn | · | Vienna | · | EUR | |
| BAYG | · | Budapest | · | HUF | |
| BAY1 | · | Warsaw | · | PLN | |
| BAYN | · | Bucharest | · | RON | |
| BAYNN | · | Mexico | · | MXN | |
| BAYRY | · | OTC Markets | · | USD | |
| BAYGn | · | Frankfurt | · | EUR | |
| BAYGn | · | TradeGate | · | EUR | |
| BAYNd | · | BATS Europe | · | EUR | |
| BAYGn | · | Dusseldorf | · | EUR | |
| BAYGn | · | Hamburg | · | EUR | |
| BAYNN | · | BIVA | · | MXN |
Currency in EUR
56.57
+0.01(+0.02%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.41
56.98
52 wk Range
26.64
57.84
BAYGn is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
56.4156.98
52 wk Range
26.6457.84
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BAYGn Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
60.11
Upside
+6.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings upwards for the upcoming period
BAYER AG-Exch receives Investment Bank Analyst Rating Update- Investing.com
Pro
- BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
13 Buy
4 Hold
1 Sell
Ratings:
18 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 60.11
(+6.26% Upside)
Earnings
Latest Release
03-11-2026
EPS / Forecast
0.31 / 0.42
Revenue / Forecast
10.05B / 9.89B
Compare BAYGn to Peers and Sector
Metrics to compare | BAYGn | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAYGnPeersSector | |
|---|---|---|---|---|
P/E Ratio | −38.6x | 15.4x | −0.2x | |
PEG Ratio | 0.06 | 0.01 | 0.00 | |
Price/Book | 1.9x | 2.3x | 2.6x | |
Price / LTM Sales | 1.2x | 1.8x | 2.8x | |
Upside (Analyst Target) | 6.2% | 6.9% | 63.4% | |
Fair Value Upside | Unlock | 9.0% | 9.5% | Unlock |
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. It has a commercial agreement with Neste to Jointly scale newgold winter canola for biofuels production. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Bayer (BAYGn) Share Price Today?
The Bayer share price today is 56.57.
What is the current Bayer (BAYGn) share price and day range?
As of 13-11-2026, the Bayer share price is 56.57, with a previous close of 56.56. The share price has ranged from 56.41 to 56.98 today, while the 52-week range spans from 26.64 to 57.84.
What Is the Bayer Market Cap?
As of today, Bayer market cap is 55.62B.
Does Bayer Pay Dividends? What's The Current Dividend Yield?
The Bayer dividend yield is 0.2%%.
What Is the Bayer (BAYGn) Share Price Target?
The average 12-month share price target for Bayer is 60.11, with a high estimate of 70 and a low estimate of 48.5. 13 analysts recommend buying, while 1 suggest selling, with an overall rating of Buy and +6.26% Upside potential.
What Is Bayer's Earnings Per Share (TTM)?
The Bayer EPS (TTM) is -1.47.
When Is the Next Bayer Earnings Date?
Bayer will release its next earnings report on 24-02-2027.
From a Technical Analysis Perspective, Is BAYGn a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does Bayer Trade On?
Bayer is listed and trades on the Frankfurt Stock Exchange.
What Is the Stock Symbol for Bayer?
The stock symbol for Bayer is "BAYGn."
How Many Times Has Bayer Stock Split?
Bayer has split 3 times.
How Many Employees Does Bayer Have?
Bayer has 87775 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.